It is known that cisplatin-resistant cells often have hyperactivated Akt, which leads to reduced sensitivity to apoptotic signals, increased activity of DNA repair mechanisms, and activation of survival signals, allowing cancer cells to evade cisplatin-induced apoptosis [83,84,85]. This evidence concerns the gene AKT1 and cancer.